Women’s Health Market - Forecast(2024 - 2030)

Women’s Health Market Overview

Women are likely to have fertility problems as a result of this. The most common causes of infertility are ovulation complications, endometriosis, and polycystic ovarian syndrome (PCOS). Moreover women's well-being is a priority for governments and private organizations all over the world. One of the main factors expected to drive the demand in developing countries is women's coverage plans. Various insurance schemes in the United States and Australia, for example, provide preventive care for women without charging a copayment. However, the high costs associated with clinical services and stringent regulations along with certain side-effects associate with the drugs is predicted to pose a threat to the market's growth during the forecast period 2021-2026.

Women’s Health Market Report Coverage

Key Takeaways

• Geographically, The North America region held 40.7% of the total market share in 2020 owing to the rising adoption of the women’s health products and supportive government programs and policy’s.
• increase in the population of women over 60, an increase in the adoption of unhealthy lifestyle habits, and the launch of novel medicines for women are the major driving force for Women’s Health Market during forecast period 2021-2026.
• Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Women’s Health Market.

Women’s Health Market - By Geography, 2020.

Women’s Health Market Segment Analysis- By Application

On the basis of application, the market is divided into Postmenopausal Osteoporosis, Infertility, Endometriosis, Contraceptives, Menopause, Polycystic Ovary Syndrome and Others applications. Contraceptives segment account for the highest market share in 2020 owing to the rising prevalence of unintended pregnancies, and large number of birth-control pill product launches by key players. For instance According to a study conducted by The Guttmacher Institute, there were approximately 121 million unwanted pregnancies between 2015 and 2019. Corresponding to a global average of 64 women per 1,000, aged 15 to 49.

However as a result of the high fertility-related conditions in developing countries, the hormonal infertility segment is expected to expand rapidly owing to which the segment is projected to grow at a faster CAGR of 5.8% during the forecast period 2021-2026. Hormonal imbalances, such as prolactin, estrogen, and thyroid imbalances, are becoming more common in women as a result of factors such as stress, fueling demand for medication to improve health.

Women’s Health Market Segment Analysis - By Distribution Channel

Online Pharmacies segment account for the highest market share in 2020 and is projected to grow at a CAGR of 5.9% during the forecast period 2021-2026. The dominance is due to evolving consumers and increasing demand from tier I and II cities where ecommerce penetration is increasing rapidly. Moreover, along with multiple options the customers can compare for the best price & features, from the comfort of their home or as per an individual’s preference which is further poised to increase the online Pharmacies segment.

Women’s Health Market Segment Analysis - By Geography

Based on geography, North America dominated the Women’s Health Market with a region share of 40.7% in 2020 followed by Europe and APAC. Rising adoption of the women’s health products and supportive government programs and policies are the major factors propelling the growth in this region. Furthermore, the presence of a large number of pharmaceutical companies that invest heavily in research, as well as easy access to technologically advanced instruments, is expected to propel market growth in this area.

However, Asia Pacific region is predicted to see the demand maturing in Women’s Health Market owing to the rising spending in emerging economies such as China and India, as well as increased concern about women's health. Furthermore, policymakers in developing countries are taking steps to raise awareness about Postmenopausal Osteoporosis, Infertility, Endometriosis diseases along with their diagnosis and treatment options which is further predicted to drive the market during the forecast period 2021-2026.

Women’s Health Market Drivers

Women’s Health Market Challenge

Despite the increased diseases and supportive government programs and policy’s, some factors are preventing product acceptance. The high costs associated with clinical services along with certain side-effects associate with the drugs is currently limiting the adoption of the products. Moreover the rising stringency in the government regulation also poses a major threat thereby, acting as major impediment for market's growth.

Women’s Health Market Landscape:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Women’s Health Market. Key companies of this market are Allergan, Bayer AG, Merck & Co., Inc., Pfizer, Teva Pharmaceuticals, Agile Therapeutics, Amgen, Inc., AstraZeneca, Bristol-Myers Squibb and Ferring B.V.

Developments:

Relevant reports

For more Lifesciences and Healthcare Market reports - Please click here